2.13 USD
↘ 0.15 (6.58%)AT CLOSE (03:59 PM EDT)
Alaunos Therapeutics, Inc. Common Stock
TCRTNASDAQ • USD
2.08
↘ 0.05 (2.58%)
POST MARKET (AS OF 07:57 PM EDT)
Post Market
AS OF 07:57 PM EDT
2.08
↘ 0.05 (2.58%)
Market: CLOSED
Shares of Alaunos Therapeutics, Inc. Common Stock (TCRT) are trading at $2.10. TCRT shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Oct 26, 2026.
Open?$2.32
High?$2.36
Low?$2.01
Prev. Close?$2.28
Volume?537.0K
Avg. Volume?16.0M
VWAP?$2.19
Rel. Volume?0.03x
Bid / Ask
Bid?$1.78 × 100
Ask?$2.62 × 100
Spread?$0.84
Midpoint?$2.20
Valuation & Ratios
Market Cap?5.8M
Shares Out?3.3M
Float?2.7M
Float %?78.3%
P/E Ratio?N/A
P/B Ratio?8.88
EPS?-$1.68
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.
Address
501 E LAS OLAS BLVD
FORT LAUDERDALE, FL 33301
Phone: (346) 355-4099
FORT LAUDERDALE, FL 33301
Phone: (346) 355-4099
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?65
Short Sent.?60
Piotroski F-Score?0/9Weak
Altman Z-Score?-860.65Distress
Confidence?49%Low
Short InterestSqueeze Risk
Short % of Float?30.41%Squeeze Risk
Short Interest?818.6K
Days to Cover?1.0
Free Float2.7M
Avg Daily Volume30.9M
Settlement Date2026-10-15
Financial Health
Current Ratio?0.77Weak
Quick Ratio?0.77Weak
Cash Ratio?0.14Low
Debt/Equity?0.00Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score50/100
P/E?N/A▾
P/B?8.88HIGH▾
Peers100
S&P21
P/S?1,930.76HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-1.4CHEAP▾
S&P97
EV/Sales?1,889.43HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-654.1%WEAK▾
S&P3
ROA?-281.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-2825000
Enterprise Value?$5.7M
Fundamentals ratios updated end of day